140 related articles for article (PubMed ID: 32066866)
1. Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7.
Crisà E; Kulasekararaj AG; Adema V; Such E; Schanz J; Haase D; Shirneshan K; Best S; Mian SA; Kizilors A; Cervera J; Lea N; Ferrero D; Germing U; Hildebrandt B; Martínez ABV; Santini V; Sanz GF; Solé F; Mufti GJ
Leukemia; 2020 Sep; 34(9):2441-2450. PubMed ID: 32066866
[TBL] [Abstract][Full Text] [Related]
2. Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome.
Cordoba I; González-Porras JR; Nomdedeu B; Luño E; de Paz R; Such E; Tormo M; Vallespi T; Collado R; Xicoy B; Andreu R; Muñoz JA; Solé F; Cervera J; del Cañizo C;
Cancer; 2012 Jan; 118(1):127-33. PubMed ID: 21717439
[TBL] [Abstract][Full Text] [Related]
3. The prognostic impact of loss of chromosome 7 material detected by fluorescence in situ hybridization (FISH) in myeloid malignancies.
El-Menoufy MAM; Mourad ZI; Farahat NM
J Egypt Natl Canc Inst; 2018 Dec; 30(4):133-138. PubMed ID: 30472199
[TBL] [Abstract][Full Text] [Related]
4. Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q).
Zhang R; Kim YM; Wang X; Li Y; Lu X; Sternenberger AR; Li S; Lee JY
Int J Med Sci; 2015; 12(9):719-26. PubMed ID: 26392809
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromes.
Ganster C; Müller-Thomas C; Haferlach C; Strupp C; Ogata K; Germing U; Hildebrandt B; Mallo M; Lübbert M; Müller C; Solé F; Götze KS; Vandenberghe P; Göhring G; Steinmetz T; Kröger N; Platzbecker U; Söling U; Raynaud S; Shirneshan K; Schanz J; Haase D
Genes Chromosomes Cancer; 2019 Oct; 58(10):689-697. PubMed ID: 30994215
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation.
Itonaga H; Ishiyama K; Aoki K; Aoki J; Ishikawa T; Ohashi K; Fukuda T; Ozawa Y; Ota S; Uchida N; Eto T; Iwato K; Ohno Y; Takanashi M; Ichinohe T; Atsuta Y; Miyazaki Y
Bone Marrow Transplant; 2019 Sep; 54(9):1471-1481. PubMed ID: 30718803
[TBL] [Abstract][Full Text] [Related]
7. Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical/pathologic features compared to -7/del(7q) MDS.
Slovak ML; O'Donnell M; Smith DD; Gaal K
Cancer Genet Cytogenet; 2009 Sep; 193(2):78-85. PubMed ID: 19665067
[TBL] [Abstract][Full Text] [Related]
8. CSNK1A1 mutations and isolated del(5q) abnormality in myelodysplastic syndrome: a retrospective mutational analysis.
Smith AE; Kulasekararaj AG; Jiang J; Mian S; Mohamedali A; Gaken J; Ireland R; Czepulkowski B; Best S; Mufti GJ
Lancet Haematol; 2015 May; 2(5):e212-21. PubMed ID: 26688096
[TBL] [Abstract][Full Text] [Related]
9. Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia.
Bidet A; Dulucq S; Smol T; Marceau-Renaut A; Morisset S; Coiteux V; Noël-Walter MP; Nicolini FE; Tigaud I; Luquet I; Struski S; Gaillard B; Penther D; Tondeur S; Nadal N; Hermet E; Véronèse L; Réa D; Gervais C; Theisen O; Terré C; Cony-Makhoul P; Lefebvre C; Gaillard JB; Radford I; Vervaeke AL; Barin C; Chapiro E; Nguyen-Khac F; Etienne G; Preudhomme C; Mahon FX; Roche-Lestienne C;
Haematologica; 2019 Jun; 104(6):1150-1155. PubMed ID: 30573507
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
[TBL] [Abstract][Full Text] [Related]
11. Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases.
Merlat A; Lai JL; Sterkers Y; Demory JL; Bauters F; Preudhomme C; Fenaux P
Leukemia; 1999 Feb; 13(2):250-7. PubMed ID: 10025899
[TBL] [Abstract][Full Text] [Related]
12. TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes.
Belickova M; Vesela J; Jonasova A; Pejsova B; Votavova H; Merkerova MD; Zemanova Z; Brezinova J; Mikulenkova D; Lauermannova M; Valka J; Michalova K; Neuwirtova R; Cermak J
Oncotarget; 2016 Jun; 7(24):36266-36279. PubMed ID: 27167113
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome.
Mallo M; Luño E; Sanzo C; Cervera J; Haase D; Schanz J; García-Manero G; del Cañizo C; Sanz GF; Solé F
Leuk Res; 2011 Jun; 35(6):834-6. PubMed ID: 21269692
[TBL] [Abstract][Full Text] [Related]
14. [Genetic defects of chromosome 5q and 7q in myeloid neoplasms].
Hosono N
Rinsho Ketsueki; 2019; 60(7):800-809. PubMed ID: 31391370
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
[TBL] [Abstract][Full Text] [Related]
16. Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH).
Tosi S; Harbott J; Haas OA; Douglas A; Hughes DM; Ross FM; Biondi A; Scherer SW; Kearney L
Leukemia; 1996 Apr; 10(4):644-9. PubMed ID: 8618441
[TBL] [Abstract][Full Text] [Related]
17. Detailed analysis of clonal evolution and cytogenetic evolution patterns in patients with myelodysplastic syndromes (MDS) and related myeloid disorders.
Schanz J; Cevik N; Fonatsch C; Braulke F; Shirneshan K; Bacher U; Haase D
Blood Cancer J; 2018 Mar; 8(3):28. PubMed ID: 29515104
[TBL] [Abstract][Full Text] [Related]
18. [Cytogenetic and clinical analysis of -7/7q- abnormalities in acute leukemia and myelodysplastic syndrome].
Meng HT; Mai WY; Chen ZM; Lou JY; Jin J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):460-3. PubMed ID: 15363131
[TBL] [Abstract][Full Text] [Related]
19. Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact.
Bacher U; Haferlach T; Schnittger S; Zenger M; Meggendorfer M; Jeromin S; Roller A; Grossmann V; Krauth MT; Alpermann T; Kern W; Haferlach C
Br J Haematol; 2014 Mar; 164(6):822-33. PubMed ID: 24372512
[TBL] [Abstract][Full Text] [Related]
20. The der(1;7)(q10;p10) defining a distinct profile from -7/del(7q) in myelodysplastic syndromes: A systematic review and meta-analysis.
Lang W; Luo Y; Wang L; Zhang Y; Hu C; Wang H; Tong H
Cancer Med; 2024 Jan; 13(1):. PubMed ID: 38164059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
